This content is from: Premium Bausch Is Adding to Glenview’s Woes Larry Robbins mixes up the hedge fund’s health-care holdings — but can’t stop the bleeding. By Michelle Celarier August 20, 2020
This content is from: Premium Short Sellers Won in Mallinckrodt Mess, but Some Hedgies Held On The specialty pharmaceutical company settled opioid lawsuit and is considering restructuring. By Michelle Celarier September 10, 2019
This content is from: Premium Larry Robbins Posts Big Gains in April The manager trimmed health care stocks, but sinking holdings have still left Glenview down by double digits. By Michelle Celarier May 28, 2020
This content is from: Portfolio Morning Brief: Suddenly Valeant’s Stock is Surging Shares of Valeant Pharmaceuticals International jumped more than 23 percent in just three days. By Stephen Taub November 09, 2017
This content is from: Premium Bill Ackman Finishes 2019 With a Bang Pershing Square triumphs, making back four years of losses — and earning incentive fees. By Michelle Celarier January 03, 2020
